Barclays’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-245,500
Closed -$14.4M – 5310
2024
Q3
$14.4M Buy
+245,500
New +$13.4M ﹤0.01% 1239
2021
Q1
– Sell
-1,584
Closed -$61K – 4776
2020
Q4
$61K Hold
1,584
– – ﹤0.01% 4327
2020
Q3
$46K Hold
1,584
– – ﹤0.01% 4648
2020
Q2
$42K Sell
1,584
-2,244
-59% -$58.4K ﹤0.01% 4999
2020
Q1
$90K Sell
3,828
-8,481
-69% -$233K ﹤0.01% 4873
2019
Q4
$364K Sell
12,309
-3,003
-20% -$79.5K ﹤0.01% 4556
2019
Q3
$429K Sell
15,312
-106,425
-87% -$3.08M ﹤0.01% 4369
2019
Q2
$3.6M Buy
+121,737
New +$3.28M ﹤0.01% 2213

Other funds holding CTVA

Barclays's CTVA Position: Q3 2026 in Review

Barclays reduced its Corteva (CTVA) stake by 0.27% in Q3 2026, selling an estimated $213K and leaving 957,399 shares worth $74.3M. The position accounts for 0.01% of the portfolio, ranked #619.

Barclays first reported a position in CTVA in Q2 2019 and has held it in 30 quarters since. The position peaked at $187M in Q4 2025. 1,226 funds tracked by Wall St. Rank hold CTVA as of Q3 2026.

  • Barclays held 957,399 shares of Corteva worth $74.3M as of Q3 2026.
  • Barclays sold 2,570 Corteva shares in Q3 2026, an estimated $213K.
  • Corteva made up 0.01% of Barclays's portfolio in Q3 2026, its #619 holding.
  • Barclays first reported a position in Corteva in Q2 2019 and has held it in 30 quarters since.
  • Barclays's Corteva position peaked at $187M in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held Corteva as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.